Cargando…

CD300f:IL-5 cross-talk inhibits adipose tissue eosinophil homing and subsequent IL-4 production

Eosinophils and their associated cytokines IL-4 and IL-5 are emerging as central orchestrators of the immune-metabolic axis. Herein, we demonstrate that cross-talk between the Ig-superfamily receptor CD300f and IL-5 is a key checkpoint that modifies the ability of eosinophils to regulate metabolic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozenberg, Perri, Reichman, Hadar, Zab-Bar, Israel, Itan, Michal, Pasmanik-Chor, Metsada, Bouffi, Carine, Qimron, Udi, Bachelet, Ido, Fulkerson, Patricia C., Rothenberg, Marc E., Munitz, Ariel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517555/
https://www.ncbi.nlm.nih.gov/pubmed/28725048
http://dx.doi.org/10.1038/s41598-017-06397-4
Descripción
Sumario:Eosinophils and their associated cytokines IL-4 and IL-5 are emerging as central orchestrators of the immune-metabolic axis. Herein, we demonstrate that cross-talk between the Ig-superfamily receptor CD300f and IL-5 is a key checkpoint that modifies the ability of eosinophils to regulate metabolic outcomes. Generation of Il5 (Tg) /Cd300f (−/−) mice revealed marked and distinct increases in eosinophil levels and their production of IL-4 in the white and brown adipose tissues. Consequently, Il5 (Tg) /Cd300f (−/−) mice had increased alternatively activated macrophage accumulation in the adipose tissue. Cd300f (−/−) mice displayed age-related accumulation of eosinophils and macrophages in the adipose tissue and decreased adipose tissue weight, which was associated with decreased diet-induced weight gain and insulin resistance. Notably, Il5 (Tg) /CD300f (−/−) were protected from diet-induced weight gain and glucose intolerance. These findings highlight the cross-talk between IL-5 receptor and CD300f as a novel pathway regulating adipose tissue eosinophils and offer new entry points for therapeutic intervention for obesity and its complications.